Trial
NCT01389076
Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
GlaxoSmithKline
Condition
Follicular Lymphoma
Intervention
Bexxar
Why stopped
Bexxar isn't being produced by the manufacturer as of Feb. 2014
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-30